<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Intracranial percutaneous transluminal balloon angioplasty (<z:mp ids='MP_0002633'>PTA</z:mp>) has been used as a technique of last resort in the treatment of intracranial atherosclerotic disease when medical and surgical alternatives have failed or cannot be applied </plain></SENT>
<SENT sid="1" pm="."><plain>The major risks associated with <z:mp ids='MP_0002633'>PTA</z:mp> include intracranial vessel rupture and abrupt vessel dissection causing occlusion </plain></SENT>
<SENT sid="2" pm="."><plain>Angioplasty techniques in the extracranial circulation have been improved by the development of safe stent technology in combination with potent antiplatelet agents </plain></SENT>
<SENT sid="3" pm="."><plain>We report three successful cases of symptomatic intracranial atherosclerotic disease in middle-aged adults treated by endovascular <z:mp ids='MP_0002633'>PTA</z:mp> followed by deployment of coronary stents </plain></SENT>
</text></document>